Page 1428 - Small Animal Internal Medicine, 6th Edition
P. 1428

1400   PART XIII   Hematology


              Carriers of the defect may be asymptomatic but usually   thrombocytopenia is present (70,000-125,000/µL), which is
            have prolonged clotting times in vitro. Certain factor defi-  likely caused by an excessive consumption of platelets from
  VetBooks.ir  ciencies (so-called contact factors), including factors XII and   protracted bleeding.
                                                                   These animals usually require immediate transfusions of
            XI,  Fletcher  factor  (prekallikrein),  and  HMWK,  are  also
            found in otherwise asymptomatic animals (i.e., no excessive
                                                                 tion factors (and packed RBCs if the animal is anemic). It
            bleeding)  with  a  markedly  prolonged  aPTT.  However,   WFB or FFP (or cryopoor plasma) to replenish the coagula-
            massive  and  often  life-threatening  postoperative  bleeding   may take 8 to 12 hours before vitamin K therapy appreciably
            starting 24 to 36 hours after surgery is common in dogs with   shortens the OSPT and subsequently decreases bleeding.
            factor XI deficiency.                                  Vitamin K is available in several forms, but vitamin K 1  is
              Most  dogs  and  cats  with  congenital  coagulopathies  are   the most effective. It is available for oral or parenteral use.
            treated with supportive and transfusion therapies; no other   Intravenous  administration  of  vitamin  K  is  not  recom-
            treatments appear to be beneficial, but anecdotally, amino-  mended  because of  the  risk  of  anaphylactic  reactions or
            caproic acid may help control bleeding. There is ongoing   Heinz  body  formation;  intramuscular  injections  in  a  dog
            research on gene therapy in canine models of hemophilia   with a coagulopathy usually result in hematoma formation.
            and other inherited coagulopathies. As with animals with   Subcutaneous administration of vitamin K 1  with a 25-gauge
            other congenital defects, dogs and cats with coagulopathies   needle (loading dose 5 mg/kg, followed in 8 hours by 2.5 mg/
            should not be bred.                                  kg subcutaneously [SC] q8h) is preferred if the patient is
                                                                 properly hydrated. Administration of oral loading doses of
            VITAMIN K DEFICIENCY                                 vitamin K 1  has been advocated for the treatment of dogs with
            Vitamin K deficiency in small animals usually results from   rodenticide poisoning (5 mg/kg with a fatty meal, then
            the  ingestion  of  vitamin  K  antagonists  (e.g.,  warfarin,   2.5 mg/kg q8-12h); this is my preferred treatment. Because
            diphacinone, brodifacoum, bromadiolone), although it can   vitamin K is lipid-soluble, its absorption is enhanced if given
            also occur as a consequence of malabsorption in dogs and   with fatty meals. Animals with cholestatic or malabsorptive
            cats with obstructive cholestasis, infiltrative bowel disease,   syndromes may require continued subcutaneous injections
            or  liver  disease.  Four  clotting  factors  are  vitamin  K–  of vitamin K. In critical cases the OSPT should be monitored
            dependent: factors II, VII, IX, and X. Proteins C and S, two   every 8 hours until it normalizes.
            natural  anticoagulants,  are  also  vitamin  K–dependent.   If the anticoagulant is known to be warfarin or another
            Because  of  its  clinical  relevance,  the  following  discussion   first-generation hydroxycoumarin, 1 week of oral vitamin K 1
            focuses  only on rodenticide poisoning, which is relatively   is usually sufficient to reverse the coagulopathy. However, if
            common in dogs and extremely rare in cats.           it is indanedione or any of the second- or third-generation
              Most dogs with toxicity are evaluated because of acute   anticoagulants, oral vitamin K 1  therapy must be maintained
            collapse and a possible history of rodenticide ingestion.   for at least 3 weeks and possibly as long as 6 weeks. Most
            Coughing, thoracic pain, and dyspnea are also common.   currently available rodenticides contain second- and third-
            These dogs usually have clinical signs compatible with sec-  generation anticoagulants.  If the  rodenticide  ingested  is
            ondary bleeding, such as hematomas and bleeding into body   unknown, the animal should be treated for 1 week, at which
            cavities. The most common site of bleeding in dogs evaluated   time vitamin K treatment is discontinued. An OSPT is then
            at our clinic is the thorax; some dogs have superficial skin   determined within 24 to 48 hours of the last dose. If the
            bruising in areas of friction, such as the axilla or groin. Other   OSPT is prolonged, therapy should be reinstituted and main-
            abnormalities include pale mucous membranes, anemia   tained for 2 more weeks and the OSPT reevaluated at the end
            (usually regenerative if sufficient time has elapsed since the   of this period.
            acute bleeding episode), and hypoproteinemia. Sudden
            death may occur as a result of central nervous system or
            pericardial hemorrhage.                              MIXED (COMBINED) HEMOSTATIC
              If the rodenticide has been ingested minutes to hours   DEFECTS
            before presentation, induced vomiting and the administra-
            tion of activated charcoal may eliminate or neutralize most   DISSEMINATED INTRAVASCULAR
            of it. If the ingestion is questionable and no clinical signs of   COAGULATION
            coagulopathy are present (e.g., hemothorax, hemoabdomen,   DIC, previously called consumptive coagulopathy or defibri-
            bruising), determination of the OSPT is recommended.   nation syndrome, is a complex syndrome in which excessive
            Because factor VII is the shortest lived vitamin K–dependent   intravascular  coagulation  leads  to  multiple-organ  micro-
            protein (circulating half-life, 4-6 hours), the OSPT is usually   thrombosis (multiple organ failure [MOF]) and paradoxic
            prolonged before spontaneous bleeding becomes evident.  bleeding caused by the inactivation or excessive consump-
              The typical hemostasis screen in a dog with symptomatic   tion of platelets and clotting factors as a result of enhanced
            vitamin  K  deficiency  reveals  marked  prolongation  of  the   fibrinolysis.  DIC  is  not  a  specific  disorder  but  rather  a
            OSPT and aPTT; this is one of the few clinical situations in   common pathway in a variety of disorders. Moreover, DIC
            which the OSPT is typically longer than the aPTT. The FDP   constitutes a dynamic phenomenon in which the patient’s
            test is positive in more than half of affected dogs and mild   status and the results of coagulation tests change markedly,
   1423   1424   1425   1426   1427   1428   1429   1430   1431   1432   1433